ADC Therapeutics SA (ADCT) Stock
NYSE · ADCT
1.05
Fundamentals
Market cap
$134.05M
Price / Earnings ratio
-1.4x
Price / Sales ratio
1.7x
Price / Book ratio
-0.6x
Return on assets
-0.5%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About ADC Therapeutics SA
No description available.
SectorHealthcare
IndustryBiotechnology
Employees188
CEODr. Ameet Mallik M.B.A., M.S.
IPO DateMay 15, 2020
HeadquartersEpalinges, Switzerland
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Ameet Mallik M.B.A., M.S. | CEO & Director | 1973 |
| Mr. Jose I. Carmona M.B.A. | Chief Financial Officer | 1972 |
| Dr. Mohamed Zaki M.D., Ph.D. | Chief Medical Officer | 1965 |
| Ms. Lisa Michelle Kallebo | Corporate Controller & Chief Accounting Officer | — |
| Dr. David S. Ege Ph.D. | Chief Technical Officer | 1974 |
| Ms. Nicole Riley | Head of Investor Relations & Corporate Communications | — |
| Mr. Peter J. Graham Esq. | Secretary and Chief Legal & Compliance Officer | 1967 |
| Ms. Kimberly Pope | Senior VP & Chief People Officer | 1967 |
| Ms. Kristen Harrington-Smith | Chief Commercial Officer | 1973 |
| Ms. Marcy Graham | Investor Relations Officer | 1967 |
Fundamentals
Valuation
Market cap$134.05M
Price-to-sales ratio1.70
Price-to-book value-0.59
Price-earnings ratio-1.40
Return on Equity65.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-0.60
Income Statement
Average volume1,794,577
EBITDA$-84.50M
1 year high (52w)$4.98
1 year low (52w)$0.78
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



